Cargando…
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B
BACKGROUND AND AIMS: The impact of nonalcoholic fatty liver disease (NAFLD) on the treatment outcome of chronic hepatitis B (CHB) is undefined and deserves an in-depth investigation. METHODS: Histologically-proven CHB receiving first-line antiviral regimens as initial therapy was enrolled and groupe...
Autores principales: | Zhang, Siyu, Zhang, Xiaoxiao, Jin, Huiming, Dou, Yao, Li, Lu, Yuan, Xiwei, Dong, Chen, Hou, Mengmeng, Nan, Yue-min, Shang, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647108/ https://www.ncbi.nlm.nih.gov/pubmed/36406311 http://dx.doi.org/10.14218/JCTH.2022.00066 |
Ejemplares similares
-
Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis
por: Yuan, Xiwei, et al.
Publicado: (2023) -
Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021) -
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023) -
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018) -
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
por: Huang, Yue Ye, et al.
Publicado: (2013)